Imperative persistent interaction analysis of anticancer noscapine-ionic liquid with calf thymus DNA.
Calf thymus DNA (ct-DNA)
Ionic liquid
Molecular docking
Noscapine
Spectroscopic analysis
Journal
International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578
Informations de publication
Date de publication:
01 Nov 2022
01 Nov 2022
Historique:
received:
21
04
2022
revised:
10
08
2022
accepted:
15
08
2022
pubmed:
20
8
2022
medline:
15
10
2022
entrez:
19
8
2022
Statut:
ppublish
Résumé
In this study, we have shown the interaction between opium poppy alkaloid noscapine-based ionic liquid [Pip-Nos]OTf and ct-DNA using UV-visible absorption spectroscopy, fluorescence spectroscopy, CD, and computational studies. The absorption spectra showed a hypochromic shift with no shift in the absorption maxima suggesting groove or electrostatic binding. Fluorescence spectra showed an enhancement in fluorescence emission suggesting that the probable mode of binding should be groove binding. Ethidium bromide (EB) competitive and Ionic strength study showed the absence of intercalative and electrostatic modes of interaction. Further, CD analysis of ct-DNA suggested a groove binding mode of interaction of [Pip-Nos]OTf with ct-DNA. [Pip-Nos]OTf displayed a strong binding with the target ct-DNA with a molecular docking score of -41.47 kJ/mol with all 3D coordinates and full conformation. Also, molecular binding contact analyses depicted the stable binding of drug and ct-DNA with potential hydrogen bonds and hydrophobic interactions. The structural superimposition dynamics analysis showed the stable binding of [Pip-Nos]OTf with the ct-DNA model through RMSD statistics. Moreover, the ligand interaction calculations revealed the involvement of large binding energy along with a high static number of molecular forces including the hydrogen bonds and hydrophobic interactions in their complexation. These significant results report the potency of [Pip-Nos]OTf and its important futuristic role in cancer therapeutics.
Identifiants
pubmed: 35985396
pii: S0141-8130(22)01809-8
doi: 10.1016/j.ijbiomac.2022.08.106
pii:
doi:
Substances chimiques
Ionic Liquids
0
Ligands
0
Noscapine
8V32U4AOQU
DNA
9007-49-2
calf thymus DNA
91080-16-9
Ethidium
EN464416SI
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
415-425Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.